| dc.contributor.author | Pittaway, JFH | en_US |
| dc.contributor.author | Guasti, L | en_US |
| dc.date.accessioned | 2019-11-27T12:32:00Z | |
| dc.date.available | 2018-08-02 | en_US |
| dc.date.issued | 2019-02 | en_US |
| dc.identifier.issn | 0952-5041 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/61582 | |
| dc.description | This manuscript has been accepted for publication in Journal of Molecular Endocrinology , but the version presented here has not yet been copy-edited, formatted or proofed. Consequently, Bioscientifica accepts no responsibility for any errors or omissions it may contain. The definitive version is now freely available at https://doi.org/10.1530/JME-18-0122. 2019.” | en_US |
| dc.description.sponsorship | The support of Rosetrees Trust and Barts Charity is greatly acknowledged. J P is supported by a Joan Adams Research Fellowship and a Barts and The London Charity Academic Clinical Fellowship. | en_US |
| dc.format.extent | R105 - R119 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | JOURNAL OF MOLECULAR ENDOCRINOLOGY | en_US |
| dc.subject | adrenal cortex | en_US |
| dc.subject | cancer | en_US |
| dc.subject | molecular genetics | en_US |
| dc.subject | stem cell | en_US |
| dc.title | Pathobiology and genetics of adrenocortical carcinoma | en_US |
| dc.type | Article | |
| dc.rights.holder | 2019 Society for Endocrinology | |
| dc.identifier.doi | 10.1530/JME-18-0122 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000457061100002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 2 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 62 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | Investigating the role of the Notch atypical ligand delta-like homologue 1 (DLK1) in adrenocortical carcinoma::Medical Research Council | en_US |
